Molecular Vaccines Volume 2
From Prophylaxis to Therapy
(Sprache: Englisch)
This book examines all aspects of global molecular vaccine research and development. It describes the development of new vaccines from bench to preclinical to clinical studies and launch to the market under EMA and FDA guidelines.
Leider schon ausverkauft
versandkostenfrei
Buch
219.99 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „Molecular Vaccines Volume 2 “
This book examines all aspects of global molecular vaccine research and development. It describes the development of new vaccines from bench to preclinical to clinical studies and launch to the market under EMA and FDA guidelines.
Klappentext zu „Molecular Vaccines Volume 2 “
This title discusses all aspects of non-infectious and non-cancer- so called NINC - vaccines. Hypertension, diabetes and allergy vaccine development are referred to as well as the use of adjuvants and nanotechnology in vaccine development. The way of novel vaccines from bench to preclinical to clinical studies and launch to the market under EMEA (European Medicines Agency) and FDA (Food and Drug Administration) guidelines are described in-depth. The book is therefore of interest for researchers and clinicians engaged in vaccine development and molecular vaccine application.
Inhaltsverzeichnis zu „Molecular Vaccines Volume 2 “
Non-infectious and non-cancer vaccines.- Adjuvants and nanotechnology.- In silico and delivery systems.- Patenting, manufacturing, registration.
Autoren-Porträt
Dr. Matthias Giese, Heidelberg, Germany
Bibliographische Angaben
- 2013, 2014, 423 Seiten, Maße: 18,3 x 26 cm, Gebunden, Englisch
- Herausgegeben: Matthias Giese
- Verlag: Springer
- ISBN-10: 331900977X
- ISBN-13: 9783319009773
- Erscheinungsdatum: 20.11.2013
Sprache:
Englisch
Kommentar zu "Molecular Vaccines Volume 2"
Schreiben Sie einen Kommentar zu "Molecular Vaccines Volume 2".
Kommentar verfassen